ABL1 and acute myeloid leukemia: These observations demonstrate that the NUP214-ABL1 variant of AML shows a genetic heterogeneity that probably leads to a biological heterogeneity of these patients and possibly also a heterogeneity with regard to chemosensitivity/prognosis of these patients.